Previous close | 8.13 |
Open | 8.05 |
Bid | 7.86 x 100 |
Ask | 7.95 x 200 |
Day's range | 7.85 - 8.30 |
52-week range | 2.18 - 13.68 |
Volume | |
Avg. volume | 658,088 |
Market cap | 505.296M |
Beta (5Y monthly) | 0.74 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Advances in Nomlabofusp Development and Strategic Financing Position Company for Future
Key Insights Given the large stake in the stock by institutions, Larimar Therapeutics' stock price might be vulnerable...